A significant advance in cancer study is arising with the use of VHH fragments to reactivate mutated p53. This essential tumor protector protein is frequently disabled in many kinds of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research